Cargando…
Effectiveness of Early Favipiravir Therapy in Hospitalised COVID-19 Patients
COVID-19 is a disease caused by a novel coronavirus with no specific, standard treatment. We investigated the clinical data of COVID-19 patients admitted to King Fahad Specialist Hospital (KFSH) in Buraydah by comparing the patients who were treated early with favipiravir (within 3 days of admission...
Autores principales: | Tawfik, Abdulrahman, Alzahrani, Abdulrahman, Alharbi, Sami, Almitairi, Jamal, Alzahrani, Arwa, Alshehri, Mohammed Ali, Aldughaim, Mohammed S., Alothaid, Hani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259373/ https://www.ncbi.nlm.nih.gov/pubmed/35812166 http://dx.doi.org/10.1155/2022/9240941 |
Ejemplares similares
-
Sociodemographic predictors of confirmed COVID-19 mortality and hospitalization among patients in Saudi Arabia: Analyzing a national COVID-19 database
por: Alothaid, Hani, et al.
Publicado: (2022) -
The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol
por: Kazi, Mohsin, et al.
Publicado: (2023) -
Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment
por: Alothaid, Hani, et al.
Publicado: (2020) -
Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
por: Bosaeed, Mohammad, et al.
Publicado: (2021) -
Contact Lens Practices and Knowledge of Complications and its Association With Refractive Error in Saudi Arabia
por: Alzahrani, Othman, et al.
Publicado: (2021)